HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Structure-activity relationships of pyrrole hydrazones as new anti-tuberculosis agents.

Abstract
Preliminary investigations of our research team have shown that some pyrrole hydrazones posses strong inhibitory activity against the tuberculosis bacilli, and thus represent a new perspective for development of anti-tuberculosis agents. In this work the anti-tuberculosis activity of an in-house series of pyrrole hydrazones was investigated by quantitative structure-activity relationships (QSAR) analysis and by pharmacophore modelling. Different constitutional, topological, physicochemical, and quantum-mechanical descriptors of the chemical structure were calculated. The QSAR models included the number of chlorine, fluorine and nitrogen atoms, molecular flexibility and shape indexes, and magnitudes of charged molecular surfaces areas and hydrophobic volumes, suggesting importance of these structural characteristics for the activity. Next, a pharmacophore analysis was applied. A possible pharmacophore responsible for the compound interactions with their biological target in the 3D space consisted of five features, including hydrophobic centres, a potential H-bond acceptor and a potential metal ligator.
AuthorsIglika Lessigiarska, Ilza Pajeva, Penka Prodanova, Maya Georgieva, Atanas Bijev
JournalMedicinal chemistry (Shariqah (United Arab Emirates)) (Med Chem) Vol. 8 Issue 3 Pg. 462-73 (May 2012) ISSN: 1875-6638 [Electronic] Netherlands
PMID22530903 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antitubercular Agents
  • Hydrazones
  • Pyrroles
Topics
  • Animals
  • Antitubercular Agents (chemical synthesis, chemistry, pharmacology)
  • Drug Design
  • Hydrazones (chemical synthesis, chemistry, pharmacology)
  • Lethal Dose 50
  • Mice
  • Microbial Sensitivity Tests
  • Models, Molecular
  • Molecular Structure
  • Mycobacterium tuberculosis (drug effects)
  • Pyrroles (chemical synthesis, chemistry, pharmacology)
  • Quantitative Structure-Activity Relationship
  • Toxicity Tests, Acute

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: